A Double-Blind, Placebo-Controled, Randomized Study to Evaluate Safety, Tolerability, and Immunogenicity After 1 and 2 Doses of Zoster Vaccine.
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 03 Aug 2008 Additional trial identifier V211-007 reported by ClinicalTrials.gov.
- 03 Aug 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 15 Oct 2005 New trial record.